SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma Science informs about updates

16 Mar 2021 Evaluate
Solara Active Pharma Science has informed that the ordinary resolution has been passed by the Members of the Company by requisite majority. The resolution is deemed as passed on the last date of the e-voting, Sunday, March 14, 2021. Also enclosed the Voting Results (Annexure A) and Report of the Scrutinizer on remote e-voting in accordance with Rule 22 of the Companies (Management and Administration) Rules, 2014.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

499.25 9.95 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×